Preface

Preface

From Annual Report 2018

greeting

Akio IKEDA, M.D., Ph.D.
Chairman and Professor
Department of Epilepsy, Movement Disorders and Physiology
Kyoto University Graduate School of Medicine

Since two years have past after we have the issued the third annual reports of the Department of Epilepsy, Movement Disorders and Physiology, Kyoto University Graduate School of Medicine, it is again my great honor and pleasure that we could issue the fourth annual report. We made it for the last two years because we hosted the 51st Annual Congress of the Japan Epilepsy Society (November 3-5, 2017, Kyoto). We appreciate very much all of you who kindly gave the very important comments and suggestion, upon the previous annual reports from other places and fields.

First of all, since the establishment of this department in August 2013, we have been supported, as the endowed department, by GlaxoSmithKline K.K., Niho Kohden Co., Otsuka Pharmaceutical Co., and UCB Japan Co. Ltd. Within the Kyoto University, we greatly appreciate the warmest and continuous support by the Department of Neurology (chaired by Prof. Ryosuke Takahashi), and also by the Departments of Neurosurgery (Prof. Susumu Miyamoto), Psychiatry (Prof. Toshiya Murai), Pediatrics (Prof. Toshio Heike), and Diagnostic Imaging & Nuclear Medicine (Prof. Kaori Togashi).

Based on or in addition to the daily clinical practice for patients with epilepsy and movement disorders in the Kyoto University Hospital, the aim of this Department was originally planned as follows. 1) Clinical Research: To solve pathophysiology of epilepsy and movement disorders, and to develop new treatments that could lead to the advanced medical care. We also aim at standardizing it in clinical practice. 2) Translatable and Translational Research: To promote clinical practice and research of clinical neurophysiology on epilepsy and movement disorders and its clinical application, because basic- and clinical epileptology and movement disorders are very closely related to neurophysiological knowledge and methods. 3) Education: To provide the integrated teaching opportunity for training of physician-scientists, clinical specialists and leaders of related fields internationally. For instance, since 2011, We started the EEG/Epilepsy fellowship program in cooperation with department of Neurology and we also have provided education course in Japan Neurology Society fellowship program (EEG course) since 2017. 4) Industry-academia collaboration under the appropriate COI management.

Upon the completion of the fifth year, we again greatly appreciate all of the Departments of Kyoto University Graduate School of Medicine and all of the Clinical Divisions of the Kyoto University Hospital for their warmest and sincere support to our activity. Without this supports, we could not complete any of them by all means that were reported in this annual report. It was also strongly supported by so many collaborators, researchers and friends in Japan and also internationally.

In this annual report, we are also very pleased to report the outcome and the current state of industry-academia collaboration. We hope that it may represent a positive face of endowment department in general and that it may help industry partners understand the significance of the endowment department in the future plan.

We again tried to summarize what we could do and not, which help us analyze and understand the situation, and then help us improve and modify the current condition, and also start the new concerns. We would greatly appreciate your any feedback to us that is very helpful for our future contribution to the patients close to or distant from us.

At the end of my preface, I thank all of our friends very much whoever kindly worked hard to make and edit this annual report.

December, 2018

With my best wishes,

greeting_en

ps: Following the completion of endowment departmenrt in May 2018, Department of Epilepsy, Movement Disorders andPhysiology continue as the Industry-Academia Collaboration Course, Kyoto University Graduate School of Medicine.

 

Preface

From Annual Report 2016

greeting

Akio IKEDA, M.D., Ph.D.
Chairman and Professor
Department of Epilepsy, Movement Disorders and Physiology
Kyoto University Graduate School of Medicine

Since two years have past after we have the issued the first and second annual reports of the Department of Epilepsy, Movement Disorders and Physiology, Kyoto University Graduate School of Medicine, it is again my great honor and pleasure that we could issue the third annual report. We appreciate very much all of you who kindly gave the very important comments and suggestion, upon the previous annual reports from other places and fields.

First of all, since the establishment of this department in August 2013, we have been supported, as the endowed department, by GlaxoSmithKline K.K., Niho Kohden Co., Otsuka Pharmaceutical Co., and UCB Japan Co. Ltd. Within the Kyoto University, we greatly appreciate the warmest and continuous support by the Department of Neurology (chaired by Prof. Ryosuke Takahashi), and also by the Departments of Neurosurgery (Prof. Susumu Miyamoto), Psychiatry (Prof. Toshiya Murai), Pediatrics (Prof. Toshio Heike), and Diagnostic Imaging & Nuclear Medicine (Prof. Kaori Togashi).

Based on or in addition to the daily clinical practice for patients with epilepsy and movement disorders in the Kyoto University Hospital, the aim of this Department was originally planned as follows.
1)Clinical Research: To solve pathophysiology of epilepsy and movement disorders, and to develop new treatments that could lead to the advanced medical care. We also aim at standardizing it in clinical practice.
2)Translatable and Translational Research: To promote clinical practice and research of clinical neurophysiology on epilepsy and movement disorders and its clinical application, because basic- and clinical epileptology and movement disorders are very closely related to neurophysiological knowledge and methods.
3)Education: To provide the integrated teaching opportunity for training of physician-scientists, clinical specialists and leaders of related fields internationally.
4)Industry-academia collaboration under the appropriate COI management

Upon the completion of the third year, we again greatly appreciate all of the Departments of Kyoto University Graduate School of Medicine and all of the Clinical Divisions of the Kyoto University Hospital for their warmest and sincere support to our activity. Without this supports, we could not complete any of them by all means that were reported in this annual report. It was also strongly supported by so many collaborators, researchers and friends in Japan and also internationally.

In this annual report, we are also very pleased to report the outcome and the current state of industry-academia collaboration. We hope that it may represent a positive face of endowment department in general and that it may help industry partners understand the significance of the endowment department in the future plan.

We again tried to summarize what we could do and not, which help us analyze and understand the situation, and then help us improve and modify the current condition, and also start the new concerns. We would greatly appreciate your any feedback to us that is very helpful for our future contribution to the patients close to or distant from us.

At the end of my preface, I thank all of our friends very much whoever kindly worked hard to make and edit this annual report.

August 2016

With my best wishes,

greeting_en

Preface

From Annual Report 2015

greeting

Akio IKEDA, M.D., Ph.D.
Chairman and Professor
Department of Epilepsy, Movement Disorders and Physiology
Kyoto University Graduate School of Medicine

Since one year has past after we have issued the first annual report of the Department of Epilepsy, Movement Disorders and Physiology, Kyoto University Graduate School of Medicine in 2014, it is again my great honor and pleasure that we could issue the second annual report. We appreciate very much all of you who kindly gave the very important comments and suggestion, upon the first annual reports from all over the place.
First of all, since the establishment of this department in August 2013, we have been supported, as the endowed department, by GlaxoSmithKline K.K., Niho KohdenCo., Otsuka Pharmaceutical Co., and UCB Japan Co. Ltd. Within the Kyoto University,we greatly appreciate the warmest and continuous support by the Department ofNeurology (chaired by Prof. Ryosuke Takahashi), and also by the Departments ofNeurosurgery (Prof. Susumu Miyamoto), Psychiatry (Prof. Toshiya Murai), Pediatrics (Prof. Toshio Heike), and HumanBrain Research Center (Prof. Hidenao Fukuyama) and Diagnostic Imaging & Nuclear Medicine (Prof. Kaori Togashi).

Based on or in addition to the daily clinical practice for patients with epilepsy and movement disorders in the KyotoUniversity Hospital, the aim of this Department was originally planned as follows.
1) Clinical Research: To solve pathophysiology of epilepsy and movement disorders, and to develop new treatments that could lead to the advanced medical care. We also aim at standardizing it in clinical practice.
2) Translatable and Translational Research: To promote clinical practice and research of clinical neurophysiology on epilepsy and movement disorders and its clinical application, because basic- and clinical epileptology and movement disorders are very closely related to neurophysiological knowledge and methods.
3) Education: To provide the integrated teaching opportunity for training of physician-scientists, clinical specialists and leaders of related fields internationally.

Upon the completion of the second year, we again greatly appreciate all of the Departments of Kyoto University Graduate School of Medicine and all of the Clinical Divisions of the Kyoto University Hospital for their warmest and strong support to our activity. Without their support, we could not complete any of them by all means that were reported in this annual report. It was also strongly supported by so many collaborators, researchers and friends inJapan and also internationally.

We again tried to summarize what we could do and not, which help us analyze and understand the situation, and then help us improve and modify the current condition, and also start the new concerns. We would greatly appreciate your any feedback to us that is very helpful for our future contribution to the patients close to or distant from us.

At the end of my preface, I thank all of our friends very much whoever kindly worked hard to make and edit this annual report.

August 2015

With my best wishes,

greeting_en

Preface

From Annual Report 2014

greeting

Akio IKEDA, M.D., Ph.D.
Chairman and Professor
Department of Epilepsy, Movement Disorders and Physiology
Kyoto University Graduate School of Medicine

It is my great honor and pleasure that we could issue the first annual report of the Department of Epilepsy, Movement Disorders and Physiology, Kyoto University Graduate School of Medicine. It was decided to establish in June, 2013, and then I was appointed as the Chairman and the Professor of this Department in August,2013. It is the endowed Department, supported by GlaxoSmithKline K.K., NIHONKOHDEN CORPORATION, Otsuka Pharmaceutical Co., and UCB Japan Co., Ltd. Theactivity of this Department is officially supported by the Department of Neurology(chaired by Prof. Ryosuke Takahashi), and also by the Departments of Neurosurgery(Prof. Susumu Miyamoto), Human Brain Research Center (Prof. Hidenao Fukuyama),Psychiatry (Prof. Toshiya Murai), and Pediatrics (Prof. Toshio Heike).

Based on or in addition to the daily, clinical practice for patients with epilepsy and movement disorders in the KyotoUniversity Hospital, the aim of this Department was planned as follows.

1) To solve pathophysiology of epilepsy and movement disorders, and to develop new treatments that could lead to the advanced medical care. We also aim at standardizing it in clinical practice.
2) To promote clinical practice and research of clinical neurophysiology on epilepsy and movement disorders and its clinical application, because basic- and clinical epileptology and movement disorders are very closely related to neurophysiological knowledge and methods.
3) To provide the integrated teaching opportunity for training of physcian-scientists, clinical specialists and leaders of related fields internationally.

In the last year we tried to conduct our initial purposes. However, since it was the first year after launching, it wasspent more to prepare to conduct the various listed activities. Fortunately, we could at least partly continue our activity because many of us used to do in the Department of Neurology until its was founded, because we were allowed to continue with the great support by the Department of Neurology (Prof. Takahashi).

Upon the completion of the first year, we greatly appreciate all of the Departments of Kyoto University Graduate School of Medicine and all of the Clinical Divisions of the Kyoto University Hospital for their warmest and sincere support to our activity. Without this support, we could not complete any of them by all means that were reported in this annual report. It was also strongly supported by so many collaborators, researchers and friends in Japan and also internationally.

We tried to summarize what we could do and not, which help us analyze and understand the situation, and then help us improve and modify the current condition, and also start the new concerns. We would greatly appreciate your any feedback to us which is very helpful for our future contribution to the patients in this planet.

At the end of my preface, I thank all of our friends very much whoever kindly worked hard to make and edit this annual report.

August 2014

With my best wishes,
greeting_en

▲ページトップへ